• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鉴定人类免疫缺陷病毒gp120糖蛋白中对于与CXCR4结合至关重要的保守和可变结构。

Identification of conserved and variable structures in the human immunodeficiency virus gp120 glycoprotein of importance for CXCR4 binding.

作者信息

Basmaciogullari Stéphane, Babcock Gregory J, Van Ryk Donald, Wojtowicz Woj, Sodroski Joseph

机构信息

Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Boston, Massachusetts 02115, USA.

出版信息

J Virol. 2002 Nov;76(21):10791-800. doi: 10.1128/jvi.76.21.10791-10800.2002.

DOI:10.1128/jvi.76.21.10791-10800.2002
PMID:12368322
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC136628/
Abstract

CD4 and the chemokine receptors, CXCR4 and CCR5, serve as receptors for human immunodeficiency virus type 1 (HIV-1). Binding of the HIV-1 gp120 envelope glycoprotein to the chemokine receptors normally requires prior interaction with CD4. Mapping the determinants on gp120 for the low-affinity interaction with CXCR4 has been difficult due to the nonspecific binding of this viral glycoprotein to cell surfaces. Here we examine the binding of a panel of gp120 mutants to paramagnetic proteoliposomes displaying CXCR4 on their surfaces. We show that the gp120 beta19 strand and third variable (V3) loop contain residues important for CXCR4 interaction. Basic residues from both elements, as well as a conserved hydrophobic residue at the V3 tip, contribute to CXCR4 binding. Removal of the gp120 V1/V2 variable loops allows the envelope glycoprotein to bind CXCR4 in a CD4-independent manner. These results indicate that although some variable gp120 residues contribute to the specific binding to CCR5 or CXCR4, gp120 elements common to CXCR4- or CCR5-using strains are involved in the interaction with both coreceptors.

摘要

CD4以及趋化因子受体CXCR4和CCR5作为1型人类免疫缺陷病毒(HIV-1)的受体。HIV-1的gp120包膜糖蛋白与趋化因子受体的结合通常需要先与CD4相互作用。由于这种病毒糖蛋白与细胞表面的非特异性结合,确定gp120上与CXCR4低亲和力相互作用的决定簇一直很困难。在这里,我们研究了一组gp120突变体与表面展示CXCR4的顺磁性蛋白脂质体的结合情况。我们发现,gp120的β19链和第三个可变区(V3)环包含对CXCR4相互作用很重要的残基。这两个元件的碱性残基以及V3末端的一个保守疏水残基都有助于与CXCR4的结合。去除gp120的V1/V2可变环可使包膜糖蛋白以不依赖CD4的方式与CXCR4结合。这些结果表明,虽然gp120的一些可变残基有助于与CCR5或CXCR4的特异性结合,但使用CXCR4或CCR5的毒株共有的gp120元件参与了与这两种共受体的相互作用。

相似文献

1
Identification of conserved and variable structures in the human immunodeficiency virus gp120 glycoprotein of importance for CXCR4 binding.鉴定人类免疫缺陷病毒gp120糖蛋白中对于与CXCR4结合至关重要的保守和可变结构。
J Virol. 2002 Nov;76(21):10791-800. doi: 10.1128/jvi.76.21.10791-10800.2002.
2
Identification of determinants on a dualtropic human immunodeficiency virus type 1 envelope glycoprotein that confer usage of CXCR4.鉴定1型双嗜性人类免疫缺陷病毒包膜糖蛋白上决定使用CXCR4的决定簇。
J Virol. 1998 Mar;72(3):2509-15. doi: 10.1128/JVI.72.3.2509-2515.1998.
3
Replication-competent variants of human immunodeficiency virus type 2 lacking the V3 loop exhibit resistance to chemokine receptor antagonists.缺乏V3环的2型人类免疫缺陷病毒的复制能力变体对趋化因子受体拮抗剂表现出抗性。
J Virol. 2007 Sep;81(18):9956-66. doi: 10.1128/JVI.00385-07. Epub 2007 Jul 3.
4
Envelope glycoprotein determinants of increased fusogenicity in a pathogenic simian-human immunodeficiency virus (SHIV-KB9) passaged in vivo.在体内传代的致病性猿猴-人类免疫缺陷病毒(SHIV-KB9)中,包膜糖蛋白决定了融合活性的增加。
J Virol. 2000 May;74(9):4433-40. doi: 10.1128/jvi.74.9.4433-4440.2000.
5
Ligand binding characteristics of CXCR4 incorporated into paramagnetic proteoliposomes.掺入顺磁性蛋白脂质体中的CXCR4的配体结合特性。
J Biol Chem. 2001 Oct 19;276(42):38433-40. doi: 10.1074/jbc.M106229200. Epub 2001 Aug 6.
6
Determinants of CD4 independence for a human immunodeficiency virus type 1 variant map outside regions required for coreceptor specificity.1型人类免疫缺陷病毒变体CD4非依赖性的决定因素定位于共受体特异性所需区域之外。
J Virol. 1999 Dec;73(12):10310-9. doi: 10.1128/JVI.73.12.10310-10319.1999.
7
gp120 induces cell death in human neuroblastoma cells through the CXCR4 and CCR5 chemokine receptors.gp120通过CXCR4和CCR5趋化因子受体诱导人神经母细胞瘤细胞死亡。
J Neurochem. 2000 Jun;74(6):2373-9. doi: 10.1046/j.1471-4159.2000.0742373.x.
8
Involvement of both the V2 and V3 regions of the CCR5-tropic human immunodeficiency virus type 1 envelope in reduced sensitivity to macrophage inflammatory protein 1alpha.CCR5嗜性1型人类免疫缺陷病毒包膜的V2和V3区域参与对巨噬细胞炎性蛋白1α敏感性降低的过程。
J Virol. 2000 Feb;74(4):1787-93. doi: 10.1128/jvi.74.4.1787-1793.2000.
9
Cryptic nature of a conserved, CD4-inducible V3 loop neutralization epitope in the native envelope glycoprotein oligomer of CCR5-restricted, but not CXCR4-using, primary human immunodeficiency virus type 1 strains.在CCR5限制性而非CXCR4利用型的原发性人类免疫缺陷病毒1型毒株的天然包膜糖蛋白寡聚体中,一个保守的、CD4诱导性V3环中和表位的隐秘性质。
J Virol. 2005 Jun;79(11):6957-68. doi: 10.1128/JVI.79.11.6957-6968.2005.
10
Cooperation of the V1/V2 and V3 domains of human immunodeficiency virus type 1 gp120 for interaction with the CXCR4 receptor.人类免疫缺陷病毒1型gp120的V1/V2和V3结构域与CXCR4受体相互作用的协同作用。
J Virol. 2001 Jun;75(12):5457-64. doi: 10.1128/JVI.75.12.5457-5464.2001.

引用本文的文献

1
Evolution of Multiple Domains of the HIV-1 Envelope Glycoprotein during Coreceptor Switch with CCR5 Antagonist Therapy.HIV-1 包膜糖蛋白在与 CCR5 拮抗剂治疗共受体转换过程中多个结构域的进化。
Microbiol Spectr. 2022 Aug 31;10(4):e0072522. doi: 10.1128/spectrum.00725-22. Epub 2022 Jun 21.
2
Viral dUTPases: Modulators of Innate Immunity.病毒 dUTPases:先天免疫的调节剂。
Biomolecules. 2022 Jan 28;12(2):227. doi: 10.3390/biom12020227.
3
Deep Mutational Scanning of Viral Glycoproteins and Their Host Receptors.病毒糖蛋白及其宿主受体的深度突变扫描
Front Mol Biosci. 2021 Apr 9;8:636660. doi: 10.3389/fmolb.2021.636660. eCollection 2021.
4
Functional mimetic of the G-protein coupled receptor CXCR4 on a soluble antibody scaffold.可溶性抗体支架上 G 蛋白偶联受体 CXCR4 的功能模拟物。
MAbs. 2019 May/Jun;11(4):725-734. doi: 10.1080/19420862.2019.1596703. Epub 2019 Apr 16.
5
HIV Entry and Its Inhibition by Bifunctional Antiviral Proteins.HIV的进入及其被双功能抗病毒蛋白的抑制作用。
Mol Ther Nucleic Acids. 2018 Dec 7;13:347-364. doi: 10.1016/j.omtn.2018.09.003. Epub 2018 Sep 11.
6
Experimental Estimation of the Effects of All Amino-Acid Mutations to HIV's Envelope Protein on Viral Replication in Cell Culture.对HIV包膜蛋白所有氨基酸突变对细胞培养中病毒复制影响的实验评估。
PLoS Pathog. 2016 Dec 13;12(12):e1006114. doi: 10.1371/journal.ppat.1006114. eCollection 2016 Dec.
7
A Cinnamon-Derived Procyanidin Compound Displays Anti-HIV-1 Activity by Blocking Heparan Sulfate- and Co-Receptor- Binding Sites on gp120 and Reverses T Cell Exhaustion via Impeding Tim-3 and PD-1 Upregulation.一种源自肉桂的原花青素化合物通过阻断gp120上的硫酸乙酰肝素和共受体结合位点显示抗HIV-1活性,并通过阻碍Tim-3和PD-1上调逆转T细胞耗竭。
PLoS One. 2016 Oct 27;11(10):e0165386. doi: 10.1371/journal.pone.0165386. eCollection 2016.
8
Human immunodeficiency virus and heparan sulfate: from attachment to entry inhibition.人类免疫缺陷病毒与硫酸乙酰肝素:从附着到进入抑制
Front Immunol. 2013 Nov 20;4:385. doi: 10.3389/fimmu.2013.00385.
9
Peptide-derivatized SB105-A10 dendrimer inhibits the infectivity of R5 and X4 HIV-1 strains in primary PBMCs and cervicovaginal histocultures.肽衍生的 SB105-A10 树枝状聚合物抑制原代 PBMC 和宫颈组织培养物中 R5 和 X4 HIV-1 株的感染性。
PLoS One. 2013 Oct 7;8(10):e76482. doi: 10.1371/journal.pone.0076482. eCollection 2013.
10
Structure of the CCR5 chemokine receptor-HIV entry inhibitor maraviroc complex.CCR5 趋化因子受体-人类免疫缺陷病毒进入抑制剂马拉维若复合物的结构。
Science. 2013 Sep 20;341(6152):1387-90. doi: 10.1126/science.1241475. Epub 2013 Sep 12.

本文引用的文献

1
Ligand binding characteristics of CXCR4 incorporated into paramagnetic proteoliposomes.掺入顺磁性蛋白脂质体中的CXCR4的配体结合特性。
J Biol Chem. 2001 Oct 19;276(42):38433-40. doi: 10.1074/jbc.M106229200. Epub 2001 Aug 6.
2
Mapping the determinants of the CCR5 amino-terminal sulfopeptide interaction with soluble human immunodeficiency virus type 1 gp120-CD4 complexes.绘制CCR5氨基末端硫肽与可溶性人类免疫缺陷病毒1型gp120-CD4复合物相互作用的决定因素。
J Virol. 2001 Jun;75(12):5541-9. doi: 10.1128/JVI.75.12.5541-5549.2001.
3
Loss of a single N-linked glycan allows CD4-independent human immunodeficiency virus type 1 infection by altering the position of the gp120 V1/V2 variable loops.单个N-连接聚糖的缺失通过改变gp120 V1/V2可变环的位置,使1型人类免疫缺陷病毒能够在不依赖CD4的情况下感染。
J Virol. 2001 Apr;75(7):3435-43. doi: 10.1128/JVI.75.7.3435-3443.2001.
4
Interaction between HIV type 1 glycoprotein 120 and CXCR4 coreceptor involves a highly conserved arginine residue in hypervariable region 3.1型人类免疫缺陷病毒糖蛋白120与CXCR4共受体之间的相互作用涉及高变区3中一个高度保守的精氨酸残基。
AIDS Res Hum Retroviruses. 2000 Nov 20;16(17):1821-9. doi: 10.1089/08892220050195784.
5
The plasma membrane as a combat zone in the HIV battlefield.作为HIV战场中作战区域的质膜
Genes Dev. 2000 Nov 1;14(21):2677-88. doi: 10.1101/gad.833300.
6
A biosensor assay for studying ligand-membrane receptor interactions: binding of antibodies and HIV-1 Env to chemokine receptors.一种用于研究配体 - 膜受体相互作用的生物传感器检测方法:抗体与HIV-1包膜蛋白与趋化因子受体的结合
Proc Natl Acad Sci U S A. 2000 Oct 10;97(21):11215-20. doi: 10.1073/pnas.190274097.
7
A tyrosine-sulfated peptide based on the N terminus of CCR5 interacts with a CD4-enhanced epitope of the HIV-1 gp120 envelope glycoprotein and inhibits HIV-1 entry.一种基于CCR5 N端的酪氨酸硫酸化肽与HIV-1 gp120包膜糖蛋白的CD4增强表位相互作用,并抑制HIV-1进入。
J Biol Chem. 2000 Oct 27;275(43):33516-21. doi: 10.1074/jbc.M007228200.
8
Entry of R5X4 and X4 human immunodeficiency virus type 1 strains is mediated by negatively charged and tyrosine residues in the amino-terminal domain and the second extracellular loop of CXCR4.R5X4和X4 1型人类免疫缺陷病毒毒株的进入是由CXCR4氨基末端结构域和第二个细胞外环中的带负电荷残基和酪氨酸残基介导的。
Virology. 2000 Jun 5;271(2):240-7. doi: 10.1006/viro.2000.0308.
9
Paramagnetic proteoliposomes containing a pure, native, and oriented seven-transmembrane segment protein, CCR5.含有纯的、天然的且定向的七跨膜片段蛋白CCR5的顺磁性蛋白脂质体。
Nat Biotechnol. 2000 Jun;18(6):649-54. doi: 10.1038/76501.
10
Substitutions in a homologous region of extracellular loop 2 of CXCR4 and CCR5 alter coreceptor activities for HIV-1 membrane fusion and virus entry.CXCR4和CCR5细胞外环2同源区域的替换改变了HIV-1膜融合和病毒进入的共受体活性。
J Biol Chem. 2000 Aug 4;275(31):23774-82. doi: 10.1074/jbc.M003438200.